Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects
- PMID: 15476685
- DOI: 10.1016/j.biopsych.2004.08.002
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects
Abstract
Background: Patients with bipolar disorder and schizophrenia have been shown to have neurocognitive deficits when compared with control subjects. The degree and pattern of impairment between psychiatric groups have rarely been compared, especially when subjects are psychiatrically stable.
Methods: Using a standard neurocognitive battery, we compared euthymic outpatients with bipolar disorder (n = 40), stable patients with schizophrenia (n = 20), and subjects with no psychiatric disorder (n = 22). The neurocognitive domains assessed included executive functioning, verbal memory, visual memory, procedural learning, visuoconstructive ability, and language functions. Effect sizes were calculated for each cognitive domain across groups.
Results: Stable schizophrenic subjects demonstrated a generalized cognitive impairment across most domains compared with control subjects, with average effect sizes of .9. Euthymic bipolar subjects were significantly impaired compared with control subjects only in executive functioning (Wisconsin Card Sorting Task) and verbal memory (California Verbal Learning Test) domains (effect sizes in the .8-.9 range). Performance on the executive function measures was bimodal among bipolar subjects, suggesting two subgroups: one with relatively normal and one with impaired executive functioning. No significant differences between the bipolar patient group and control subjects were observed in visuoconstructive ability, procedural learning, or language function.
Conclusions: Both euthymic bipolar subjects and relatively stable schizophrenic subjects differed from control subjects in neurocognitive function. Among schizophrenic subjects, a generalized cognitive impairment was observed, and the degree of impairment was greater in the schizophrenic compared with the bipolar subjects. Subjects with bipolar disorder were impaired in two specific domains (verbal memory and executive function). Furthermore, within the bipolar group there was a subset with relatively normal executive functioning and a subset with significant impairment. Possible reasons for the persistence of these neurocognitive deficits in some subjects with bipolar disorder during periods of euthymia are reviewed.
Similar articles
-
Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.Psychiatry Res. 2009 Oct 30;169(3):220-8. doi: 10.1016/j.psychres.2008.06.032. Epub 2009 Sep 15. Psychiatry Res. 2009. PMID: 19758705
-
[Influence of attention on an auditory-verbal learning test in schizophrenic patients].Encephale. 2002 Jul-Aug;28(4):291-7. Encephale. 2002. PMID: 12232538 French.
-
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.J Affect Disord. 2008 Aug;109(3):286-99. doi: 10.1016/j.jad.2007.12.234. Epub 2008 Mar 4. J Affect Disord. 2008. PMID: 18289698
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
[Learning potential and cognitive remediation in schizophrenia].Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Encephale. 2009. PMID: 19748372 Review. French.
Cited by
-
Common and disease-specific dysfunctions of brain systems underlying attentional and executive control in schizophrenia and bipolar disorder.Eur Arch Psychiatry Clin Neurosci. 2014 Sep;264(6):517-32. doi: 10.1007/s00406-013-0445-9. Epub 2013 Sep 24. Eur Arch Psychiatry Clin Neurosci. 2014. PMID: 24061607
-
Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.CNS Drugs. 2015 Jan;29(1):1-15. doi: 10.1007/s40263-014-0213-z. CNS Drugs. 2015. PMID: 25380674 Review.
-
Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder.Bipolar Disord. 2008 Sep;10(6):684-90. doi: 10.1111/j.1399-5618.2008.00601.x. Bipolar Disord. 2008. PMID: 18837862 Free PMC article.
-
fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects.Psychiatry Res. 2010 Apr 30;182(1):22-9. doi: 10.1016/j.pscychresns.2009.11.010. Epub 2010 Mar 15. Psychiatry Res. 2010. PMID: 20227857 Free PMC article.
-
Enhanced switching and familial susceptibility for psychosis.Brain Behav. 2018 Jun;8(6):e00988. doi: 10.1002/brb3.988. Epub 2018 Apr 25. Brain Behav. 2018. PMID: 30106252 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical